Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Is the Success of Adaptive Therapy in Metastatic Castrate Resistant Prostate Cancer Influenced by Cell-Type-Dependent Production of Prostate Specific Antigen?
by
Cavill, Rachel
, Stankova, Katerina
, Salvioli, Monica
, Vandelaer, Len
, Schneider, Katharina
in
Androgens
/ Antigens
/ Cancer Biology
/ Cell culture
/ Mathematical models
/ Metastases
/ Prostate cancer
/ Prostate-specific antigen
/ Tumors
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Is the Success of Adaptive Therapy in Metastatic Castrate Resistant Prostate Cancer Influenced by Cell-Type-Dependent Production of Prostate Specific Antigen?
by
Cavill, Rachel
, Stankova, Katerina
, Salvioli, Monica
, Vandelaer, Len
, Schneider, Katharina
in
Androgens
/ Antigens
/ Cancer Biology
/ Cell culture
/ Mathematical models
/ Metastases
/ Prostate cancer
/ Prostate-specific antigen
/ Tumors
2021
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Is the Success of Adaptive Therapy in Metastatic Castrate Resistant Prostate Cancer Influenced by Cell-Type-Dependent Production of Prostate Specific Antigen?
by
Cavill, Rachel
, Stankova, Katerina
, Salvioli, Monica
, Vandelaer, Len
, Schneider, Katharina
in
Androgens
/ Antigens
/ Cancer Biology
/ Cell culture
/ Mathematical models
/ Metastases
/ Prostate cancer
/ Prostate-specific antigen
/ Tumors
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Is the Success of Adaptive Therapy in Metastatic Castrate Resistant Prostate Cancer Influenced by Cell-Type-Dependent Production of Prostate Specific Antigen?
Paper
Is the Success of Adaptive Therapy in Metastatic Castrate Resistant Prostate Cancer Influenced by Cell-Type-Dependent Production of Prostate Specific Antigen?
2021
Request Book From Autostore
and Choose the Collection Method
Overview
Prostate-specific antigen (PSA) is the most common serum marker for prostate cancer. It is used to detect prostate cancer, to assess responses to treatment and recently even to determine when to switch treatment on and off in adaptive therapy protocols. However, the correlation between PSA and tumor volume is poorly understood. Moreover, even though there is empirical evidence that some cancer cell types produce more PSA than others, recent mathematical cancer models assume that all cell types contribute equally to the PSA level. Here, we compare time to competitive release of the PSA-based adaptive therapy protocol to that of the standard of care with continuous maximum tolerable dose under different assumptions on PSA production. In particular, we assume that androgen dependent, androgen producing, and androgen independent may contribute to the PSA production to different extents. Our results show that, regardless the assumption on how much each type contributes to PSA, adaptive therapy is always at least as good as standard of care in the sense that it prolongs the time of competitive release when resistant androgen independent cells outcompete the other types. The time to competitive release under adaptive therapy and standard of care coincides if the PSA dynamics are influenced only by the resistant cells. Furthermore, we observe that in the adaptive therapy protocol, the number of treatment cycles and their length strongly depend on the assumptions about the PSA contribution of the three types. Thus, our results suggest that investigating the patient-specific PSA dynamics is crucial to designing adaptive therapy protocols. Competing Interest Statement The authors have declared no competing interest. Footnotes * Textual changes
Publisher
Cold Spring Harbor Laboratory Press,Cold Spring Harbor Laboratory
Subject
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.